Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Large Decrease in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 78,800 shares, a drop of 27.1% from the October 31st total of 108,100 shares. Based on an average daily volume of 648,600 shares, the days-to-cover ratio is currently 0.1 days. Currently, 19.4% of the company’s shares are sold short.

Avalon GloboCare Stock Up 2.6 %

Shares of NASDAQ ALBT opened at $2.80 on Friday. The stock has a market capitalization of $3.05 million, a PE ratio of -0.14 and a beta of 0.31. The firm has a fifty day moving average of $3.09 and a 200-day moving average of $4.81. Avalon GloboCare has a 52-week low of $2.11 and a 52-week high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.